Inrobics

What Inrobics does

Inrobics Social Robotics, SL is a Spanish health-technology company headquartered at the UC3M Science Park in Leganés, Madrid, and operating as a spin-off of Universidad Carlos III de Madrid. The company develops social robotics combined with proprietary artificial intelligence to deliver rehabilitation, accompaniment, and active aging solutions for patients with neurological damage, neurodevelopmental disorders, cognitive decline, and related conditions. Its platforms target four end markets: hospitals and rehabilitation centers, special education schools, senior residences and day centers, and home-based settings. Customers include San Juan de Dios hospitals in Seville and Córdoba, the National Hospital of Paraplegics of Toledo, Niño Jesús University Children's Hospital, IRF La Salle Rehabilitation Centre, and the Community of Madrid schools.

The company's product architecture is unified by 'Alma', its proprietary social AI that motivates users, adapts to individual pace, and orchestrates therapy autonomously. On top of Alma, Inrobics sells two core lines: Inrobics Rehab, a Class I medical device with CE marking under EU Regulation 2017/745, deployed via three modules — iR Clinic (clinical use), iR Virtual (Android telerehabilitation), and iR Analytics (progress tracking) — and Inrobics Care, focused on cognitive stimulation and emotional well-being for seniors. Alma runs on physical robots, VR headsets, Android mobile devices, and the Temi robot's virtual avatar, supported by voice biometrics, NLP, and ML-based personalization.

Commercially, Inrobics employs an enterprise field-sales motion targeting healthcare institutions via a 'Request your demo' flow, with annual subscription contracts on quote-based pricing. The company has deployed across more than 20 centers reaching 3,000+ users in six countries (Spain, France, Czech Republic, Finland, Canada, South Africa) and operates a 10-language localized platform. Capital structure remains founder-controlled following a single disclosed €350,000 seed round led by Grow Venture Partners in 2022, supplemented by non-dilutive public funding from CDTI (NEOTEC), AIE, the PERTE for Cutting-Edge Health initiative, and ICEX-Next. Certifications include ISO 9001 and GDPR Article 9 compliance for health and voice biometric data.

Name

Inrobics

Legal name

INROBICS SOCIAL ROBOTICS, SL

Website

https://inrobics.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

1–10 employees

Short description

Inrobics develops CE-marked, AI-powered social robotics platforms for rehabilitation, accompaniment, and active aging. Its proprietary 'Alma' AI powers clinical, home, and educational deployments for hospitals, special education schools, and senior care facilities.

Ownership category

akta.pro rank

Product category

Medical Rehabilitation Software

NAICS

Offices of Physical, Occupational and Speech Therapists, and Audiologists (62134), Services for the Elderly and Persons with Disabilities (62412)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Healthcare & Assistive Robotics (HDAAAIAC)

akta.pro secondary industries

Digital Rehabilitation & Physical Therapy Therapeutics (HLACANAJ), Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices) (HLAHAMAG), Assistive Technology, Adaptive Equipment & Home Exercise Program Training In-Home (HSABADAN)

Keywords

• Social robotics
• Rehabilitation technology
• Healthcare AI platform
• Medical device software
• Active aging solutions

Headquarters

HQ city

Madrid

HQ country

Spain

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Operations, Others

Revenue model

1. Software Platform Subscription: Subscription-based access to Inrobics platforms (Rehab Clinic, Rehab Virtual, Rehab Analytics) for healthcare centers and professionals. Platform is offered as a certified medical device with CE marking.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels6 records

Core offering

Inrobics develops AI-powered social robotics platforms for rehabilitation, accompaniment, and active aging. Its Class I CE-marked medical device platform delivers personalized physical and cognitive training across hospitals, rehabilitation centers, special education schools, senior residences, and home settings, deployable on physical robots, VR headsets, and mobile devices.

Product overview

Inrobics offers a unified digital health platform built on social robotics and artificial intelligence, consisting of two core product lines: Inrobics Rehab (focused on rehabilitation for children and adults with neurological damage, brain injury, or neurodevelopmental disorders) and Inrobics Care (focused on accompaniment and active aging for seniors). The platform is powered by Alma, the company's proprietary social AI that enables cross-platform deployment across physical robots, Virtual Reality, Android mobile devices, and virtual avatars. Inrobics Rehab includes specialized modules: iR Clinic for clinical settings, iR Virtual for home-based telerehabilitation, and iR Analytics for progress tracking. The platform is classified as a Class I medical device with CE marking under EU Regulation 2017/745.

Differentiator

Problem solved

Functional benefit

Brands

• Alma: Exclusive social AI developed by Inrobics that motivates users, adapts to their pace, and enables professionals to invest more quality time with patients.
• Inrobics Rehab
• Inrobics Care
• iR Clinic
• iR Virtual
• iR Analytics

Products and services

• Inrobics Rehab Class I CE-marked medical device that delivers personalized physical and cognitive rehabilitation training using social robotics and AI for hospitals, rehabilitation centers, special education schools, and home rehabilitation settings.
• Inrobics Rehab Clinic (iR Clinic) Clinical version of Inrobics Rehab for healthcare professionals in hospitals and rehabilitation centers, enabling AI-powered social robot-led therapy sessions with monitoring.
• Inrobics Rehab Virtual (iR Virtual) Telerehabilitation application enabling patients to perform rehabilitation sessions remotely from home using Android mobile devices or tablets, connected to Inrobics software with an intelligent virtual therapist powered by AI.
• Inrobics Rehab Analytics (iR Analytics) Evaluation and results module that tracks patient progress, provides analytics on rehabilitation outcomes, and supports data-driven treatment plan decisions for healthcare professionals.
• Inrobics Care Social robotics solution focused on accompaniment and active aging for senior residences, day centers, and home accompaniment, providing cognitive stimulation, daily support, security, and emotional well-being for older adults.

Quantifiable outcome

• Children showed faster progress when interacting with robot vs traditional therapy in 2015 pilot study at Virgen del Rocío Hospital in Seville
• +2 more outcomes

Named customers7 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature7 records

Partnerships

Six partnerships are on record, tiered core and minor.

• Carlos III University of Madrid (UC3M)coreStrategic or Co-development PartnerInrobics is a spin-off of UC3M. The company originated from research at the university using social robotics and artificial intelligence in pediatric rehabilitation. Company operates from UC3M Science Park in Leganés, Madrid.
• National Hospital of Paraplegics of ToledocoreStrategic or Co-development PartnerDeveloping rehabilitation platform for children with neurological damage in collaboration with this specialized hospital.
• Niño Jesús University Children's HospitalcoreStrategic or Co-development PartnerCollaborating on rehabilitation platform development for children with neurological damage.
• ICEXminorGTM or Marketing PartnerInrobics participated in the ICEX-Next Export Initiation Program and received support from ICEX and co-financing from European ERDF funds for international expansion.
• C3N-IA (Innovation Center for Entrepreneurship and Artificial Intelligence)minorStrategic or Co-development PartnerInnovation center at UC3M Science Park where Inrobics is located. Hosts visits from local and regional authorities to showcase social robotics and AI technology.
• Scale LabminorGTM or Marketing PartnerInrobics participated in Scale Lab's Technology Offer Catalog presentation for useful robotics, social robotics, and AI, focusing on real-world adoption in health and social care sectors.

Scale indicators7 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• PAL Robotics: Barcelona-based maker of humanoid and social robots (TIAGo, ARI) with active healthcare and rehabilitation research deployments. Closest direct competitor given shared Spanish origin, B2B healthcare go-to-market, and overlapping use cases in assisted therapy and social robotics.
• Catalia Health: US-based developer of the Mabu social robot for chronic disease patient companionship and adherence. Directly comparable in combining a proprietary social AI with a healthcare-oriented companion robot aimed at patient engagement and clinical monitoring.
• Embodied: US-based social robotics company behind Moxie, a companion robot for healthcare and education markets. Comparable in deploying AI-driven social robots into healthcare and special-education channels, with significantly more capital raised.
• Bionik Laboratories: Commercial-stage rehabilitation robotics company selling the InMotion series of upper and lower extremity therapy robots to hospitals and clinics. Closely comparable in delivering robotic therapy equipment into clinical rehabilitation workflows.
• Tyromotion: Austrian manufacturer of robotic and sensor-based therapy devices (Armeo, Pablo, Tymo) for physical and occupational therapy. Comparable in selling therapy-assistive devices into rehabilitation clinics and hospitals across Europe.

Broad incumbents

• SoftBank Robotics: Global incumbent behind Pepper and NAO, widely used in research and clinical pilots for rehabilitation, autism therapy and senior care. Competes indirectly as a platform many institutions already own for social-robotics applications.
• Hocoma (part of DIH Medical): Swiss-origin rehabilitation robotics maker (Lokomat, Armeo, Erigo) now part of DIH Medical, serving hospitals worldwide with therapy robots. Competes in clinical rehabilitation robotics from a larger, established incumbent position.

Emerging players

• Diligent Robotics: US-based maker of the Moxi hospital service robot focused on clinical staff support workflows. Adjacent rather than directly competing in therapy, but operates in the same healthcare-robotics commercial channel.

Others

• Temi USA: Manufacturer of the Temi mobile robot platform that Inrobics uses as one of its deployment form factors. A platform/partner relationship rather than a competitor, but the most direct reference point for Inrobics' hardware economics.

Regional players

• Fourier Intelligence: China-based rehabilitation robotics company selling the RehabHub and exoskeleton platforms into Asian, Middle Eastern and emerging markets. Comparable in clinical rehab robotics but primarily competes outside Europe and the Americas.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks1 record

Key highlights6 records

Customer concentration

• Xtwitter.com/inrobics
• LinkedInlinkedin.com/company/inrobics

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds1 record

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Inrobics